Cargando…

Stem cell therapy in pain medicine

Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yong Hee, Kim, Kyung Hoon, Abdi, Salahadin, Kim, Tae Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813895/
https://www.ncbi.nlm.nih.gov/pubmed/31569916
http://dx.doi.org/10.3344/kjp.2019.32.4.245
_version_ 1783462919205289984
author Han, Yong Hee
Kim, Kyung Hoon
Abdi, Salahadin
Kim, Tae Kyun
author_facet Han, Yong Hee
Kim, Kyung Hoon
Abdi, Salahadin
Kim, Tae Kyun
author_sort Han, Yong Hee
collection PubMed
description Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate and differentiate themselves into various tissues cells. Stem cells, commonly encountered in clinical or preclinical stages, are largely classified into embryonic, adult, and induced pluripotent stem cells. Recently, stem cell transplantation has been frequently applied to the treatment of pain as an alternative or promising approach for the treatment of severe osteoarthritis, neuropathic pain, and intractable musculoskeletal pain which do not respond to conventional medicine. The main idea of applying stem cells to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathic pain. Even though various differentiation capacities of stem cells are reported, there is not enough knowledge and technique to control the differentiation into desired tissues in vivo. Even though the use of stem cells is still in the very early stages of clinical use and raises complicated ethical problems, the future of stem cells therapies is very bright with the help of accumulating evidence and technology.
format Online
Article
Text
id pubmed-6813895
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Korean Pain Society
record_format MEDLINE/PubMed
spelling pubmed-68138952019-10-30 Stem cell therapy in pain medicine Han, Yong Hee Kim, Kyung Hoon Abdi, Salahadin Kim, Tae Kyun Korean J Pain Review Article Stem cells are attracting attention as a key element in future medicine, satisfying the desire to live a healthier life with the possibility that they can regenerate tissue damaged or degenerated by disease or aging. Stem cells are defined as undifferentiated cells that have the ability to replicate and differentiate themselves into various tissues cells. Stem cells, commonly encountered in clinical or preclinical stages, are largely classified into embryonic, adult, and induced pluripotent stem cells. Recently, stem cell transplantation has been frequently applied to the treatment of pain as an alternative or promising approach for the treatment of severe osteoarthritis, neuropathic pain, and intractable musculoskeletal pain which do not respond to conventional medicine. The main idea of applying stem cells to neuropathic pain is based on the ability of stem cells to release neurotrophic factors, along with providing a cellular source for replacing the injured neural cells, making them ideal candidates for modulating and possibly reversing intractable neuropathic pain. Even though various differentiation capacities of stem cells are reported, there is not enough knowledge and technique to control the differentiation into desired tissues in vivo. Even though the use of stem cells is still in the very early stages of clinical use and raises complicated ethical problems, the future of stem cells therapies is very bright with the help of accumulating evidence and technology. The Korean Pain Society 2019-10 2019-10-01 /pmc/articles/PMC6813895/ /pubmed/31569916 http://dx.doi.org/10.3344/kjp.2019.32.4.245 Text en © The Korean Pain Society, 2019 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Han, Yong Hee
Kim, Kyung Hoon
Abdi, Salahadin
Kim, Tae Kyun
Stem cell therapy in pain medicine
title Stem cell therapy in pain medicine
title_full Stem cell therapy in pain medicine
title_fullStr Stem cell therapy in pain medicine
title_full_unstemmed Stem cell therapy in pain medicine
title_short Stem cell therapy in pain medicine
title_sort stem cell therapy in pain medicine
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813895/
https://www.ncbi.nlm.nih.gov/pubmed/31569916
http://dx.doi.org/10.3344/kjp.2019.32.4.245
work_keys_str_mv AT hanyonghee stemcelltherapyinpainmedicine
AT kimkyunghoon stemcelltherapyinpainmedicine
AT abdisalahadin stemcelltherapyinpainmedicine
AT kimtaekyun stemcelltherapyinpainmedicine